Cargando…
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
Antidepressant‐induced jitteriness/anxiety syndrome is characterized as anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, and (hypo)mania, which appear immediately after initiation or increased dosage of an antidepressant. This report descr...
Autores principales: | Shirata, Toshinori, Yano, Shinji, Noto, Keisuke, Kanno, Muneaki, Suzuki, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275282/ https://www.ncbi.nlm.nih.gov/pubmed/36847164 http://dx.doi.org/10.1002/npr2.12325 |
Ejemplares similares
-
Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline
por: Nakamura, Toshinori, et al.
Publicado: (2017) -
A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome
por: Harada, Tsuyoto, et al.
Publicado: (2014) -
Manic Episode as a Result of Adding Trazodone to a Patient under Escitalopram Treatment
por: İzci, Filiz, et al.
Publicado: (2021) -
Too Jittery to Sleep? Temporal Associations of Actigraphic Sleep and Caffeine in Adolescents
por: Mathew, Gina Marie, et al.
Publicado: (2021) -
Interrelation Between Increased BDNF Gene Methylation and High Sociotropy, a Personality Vulnerability Factor in Cognitive Model of Depression
por: Shirata, Toshinori, et al.
Publicado: (2020)